drugset / Trial / NCT06006741
Universal CAR-T Cells Targeting Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to assess the feasibility, safety and efficacy of universal CAR T cells targeting multiple myeloma. Another goal of the study is to learn more about the persistence and function of the universal CAR T cells in the body.
Timeline
- Start
- 2023-10-31
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MM-specific universal CAR T cells | Cell therapy | — | — |